The evolution of chemoradiation for glioblastoma: A modern success story

Current Oncology Reports

Volumn 8, Issue 1, 2006, Pages 50-53

  Mirimanoff, René Olivier ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; GEMCITABINE; HYDROXYUREA; METHOTREXATE; NITROSOUREA DERIVATIVE; PLATINUM DERIVATIVE; PROCARBAZINE; TAXANE DERIVATIVE; TEMOZOLOMIDE;

ANTINEOPLASTIC ACTIVITY; ASTROCYTOMA; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD BRAIN BARRIER; BLOOD TOXICITY; BRACHYTHERAPY; CANADA; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MEGADOSE; EUROPE; GLIOBLASTOMA; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; STANDARD; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DACARBAZINE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS;

EID: 31544443522     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-006-0009-5     Document Type: Review

References (16)

1. Curran WJ, Scott JB, Horton J, et al.: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993, 85:704-710.
2. Laperriere N, Zuraw L, Cairncross G, et al.: Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 2002, 64:259-273.
3. Gonzalez DG, Menten J, Bosch DA, et al.: Accelerated radiotherapy in glioblastoma multiforme: a dose-searching prospective study. Radiother Oncol 1994, 32:98-105.
4. Miralbell R, Mornex F, Greiner R, et al.: Accelerated radiotherapy, carbogen and nicotinamide in glioblastoma multiforme: report of the European Organization for Research and Treatment of Cancer trial 22933. J Clin Oncol 1999, 17:3143-3149.
5. Glioma Meta-analysis Trialists Group: Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 2002, 359:1011-1018.
6. Durando X, Lemaire JJ, Tortochaux J, et al.: High dose BCNU followed by autologous hematopoeitic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients. Bone Marrow Transplant 2003, 31:559-564.
7. Qureshi Al, Suri MF, Khan J, et al.: Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures. J Neuroncol 2001, 51:151-158.
8. Yung WK, Prados MD, Yaya-Tur R: Multicenter phase II trial of temozolomide in patients with anaplastic astrocytomas or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 1999, 17:2762-2771.
9. Yung WK, Albright RE, Olson J, et al.: A phase II study of temozolomide vs procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 2000, 83:588-593.
10. Wedge SR, Porteous JK, Glaser MG, et al.: In vitro evaluation of temozolomide combined with X-irradiation. Anticancer Drugs 1997, 8:92-97.
11. Van Rijn J, Heimans JJ, Van den Berg J, et al.: Survival of human glioma cells treated with various combinations of temozolomide and X-rays. Int J Radiat Oncol Biol Phys 2000, 47:779-784.
12. Wick W, Wick A, Schulz JB, et al.: Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage of focal adhesion kinase. Cancer Res 2002, 62:1915-1919.
13. Stupp R, Dietrich PY, Ostermann Kraljevic S, et al.: Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 2002,20:1375-1382.
14. Stupp R, Mason WP, Van den Bent MJ, et al.: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-996.
15. Hegi ME, Diserens AC, Gorlia T, et al.: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005, 352:997-1003.
16. Athanassiou H, Synodinou M, Maragoudakis E, et al.: Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. J Clin Oncol 2005, 23:2372-2377.